Patients with active CD or UC show increased expression of GBP-1 mRNA and protein in colon tissue when compared to healthy controls, and GBP-1 has been proposed as a marker for IFN-γ activity in IBD patients (Haep et al., 2015). This evidence concerns the gene GBP1 and inflammatory bowel disease.